Sushovan Guha, Ph.D. - Publications

Affiliations: 
2005 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology

110 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Javia S, Munigala S, Guha S, Agarwal B. EUS Morphology Is Reliable in Selecting Patients with Mucinous Pancreatic Cyst(s) Most Likely to Benefit from Surgical Resection. Gastroenterology Research and Practice. 2017: 9863952. PMID 29081794 DOI: 10.1155/2017/9863952  0.302
2017 Matsunaga T, Ohtsuka T, Asano K, Kimura H, Ohuchida K, Kitada H, Ideno N, Mori Y, Tokunaga S, Oda Y, Guha S, Raimondo M, Nakamura M, Tanaka M. S100P in Duodenal Fluid Is a Useful Diagnostic Marker for Pancreatic Ductal Adenocarcinoma. Pancreas. PMID 28984789 DOI: 10.1097/Mpa.0000000000000940  0.319
2017 Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Ajani JA, Hofstetter W, Lin S, Guha S, Kopetz S, Krishnan S, Maru D. Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma. Oncotarget. PMID 28404924 DOI: 10.18632/Oncotarget.15645  0.318
2016 Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, Johansson SL, Jain M, Singh S, Guha S, Are C, et al. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. The American Journal of Gastroenterology. PMID 27845339 DOI: 10.1038/Ajg.2016.482  0.331
2016 Joshi S, Cruz E, Rachagani S, Guha S, Brand RE, Ponnusamy MP, Kumar S, Batra SK. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. Molecular Oncology. PMID 27185392 DOI: 10.1016/J.Molonc.2016.04.007  0.362
2016 Rahimi E, Batra S, Thosani N, Singh H, Guha S. Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study. Digestive Diseases and Sciences. PMID 27107866 DOI: 10.1007/S10620-016-4170-X  0.372
2016 Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Rodriguez J, Ajani J, Hofstetter W, Lin S, Guha S, Kopetz S, Krishnan S, Maru D. Abstract 3815: Cyclin-dependent kinase 9: a potential therapeutic target for esophageal adenocarcinoma Cancer Research. 76: 3815-3815. DOI: 10.1158/1538-7445.Am2016-3815  0.349
2015 Chadha AS, Kocak-Uzel E, Das P, Minsky BD, Delclos ME, Mahmood U, Guha S, Ahmad M, Varadhachary GR, Javle M, Katz MH, Fleming JB, Wolff RA, Crane CH, Krishnan S. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncologica (Stockholm, Sweden). 54: 971-8. PMID 25608822 DOI: 10.3109/0284186X.2014.1000466  0.354
2015 Deorukhkar A, Ahuja N, Mercado AL, Diagaradjane P, Raju U, Patel N, Mohindra P, Diep N, Guha S, Krishnan S. Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize colorectal cancer cells to radiation. Cancer Medicine. 4: 278-92. PMID 25450478 DOI: 10.1002/Cam4.367  0.325
2015 Liu L, Xu H, Wang W, Wu C, Chen Y, Yang J, Cen P, Xu J, Liu C, Long J, Guha S, Fu D, Ni Q, Jatoi A, Chari S, et al. A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. International Journal of Cancer. Journal International Du Cancer. 136: 2216-27. PMID 25273947 DOI: 10.1002/Ijc.29242  0.316
2015 Chadha AS, Guha S, Krishnan S. Abstract CT124: A phase II randomized double blind study of curcumin with preoperative capecitabine and radiation therapy followed by surgery for rectal cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct124  0.341
2015 Chadha AS, Guha S, Krishnan S. Tu1934 Chemoradiation-Related Lymphopenia As an Independent Predictor of Inferior Survival in Patients With Locally Advanced Pancreatic Cancer Gastroenterology. 148: S-938-S-939. DOI: 10.1016/S0016-5085(15)33201-7  0.352
2014 Cui X, Zhang Y, Yang J, Sun X, Hagan JP, Guha S, Li M. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Cell Cycle (Georgetown, Tex.). 13: 1180-6. PMID 24553114 DOI: 10.4161/Cc.28111  0.368
2014 Xu C, Wallace MB, Yang J, Jiang L, Zhai Q, Zhang Y, Hong C, Chen Y, Frank TS, Stauffer JA, Asbun HJ, Raimondo M, Woodward TA, Li Z, Guha S, et al. ZIP4 is a novel diagnostic and prognostic marker in human pancreatic cancer: a systemic comparison between EUS-FNA and surgical specimens. Current Molecular Medicine. 14: 309-15. PMID 24345208 DOI: 10.2174/1566524013666131217112921  0.309
2014 Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 688-700. PMID 24240113 DOI: 10.1158/1078-0432.Ccr-13-2174  0.404
2014 Tsuboi K, Matsuo Y, Shamoto T, Shibata T, Koide S, Morimoto M, Guha S, Sung B, Aggarwal BB, Takahashi H, Takeyama H. Zerumbone inhibits tumor angiogenesis via NF-κB in gastric cancer. Oncology Reports. 31: 57-64. PMID 24220661 DOI: 10.3892/Or.2013.2842  0.346
2014 Chen W, Ayala-Orozco C, Biswal NC, Perez-Torres C, Bartels M, Bardhan R, Stinnet G, Liu XD, Ji B, Deorukhkar A, Brown LV, Guha S, Pautler RG, Krishnan S, Halas NJ, et al. Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. Nanomedicine (London, England). 9: 1209-22. PMID 24063415 DOI: 10.2217/Nnm.13.84  0.323
2014 Ghouri Y, Batra S, Rahimi E, Guha S. Non-tumor Related Gastrointestinal Bleeding in U.S. National Hospitalized Cancer Patients: 2201 The American Journal of Gastroenterology. 109. DOI: 10.14309/00000434-201410002-02201  0.317
2014 Guha S, Sinnett-Smith J, Rozengurt E. Tu1914 Identification of a Novel Protein Kinase D1 (PKD1)/ RIN1 Axis in Pancreatic Cancer Cells Gastroenterology. 146: S-871. DOI: 10.1016/S0016-5085(14)63169-3  0.542
2014 Ghouri YA, Batra S, Thosani NC, Guha S. Su1228 Increased Risk of Colorectal Cancer in Patients With Prior Ovarian Cancer Diagnosis: A Population Based US Study Gastroenterology. 146: S-408. DOI: 10.1016/S0016-5085(14)61474-8  0.341
2014 Weston BR, Ross WA, Lum P, Thirumurthi S, Miller E, Bhutani MS, Blechacz B, Bresalier RS, Davila ML, Dekovich AA, Guha S, Lee JH, Lynch PM, Pande M, Rashid A, et al. Sa1411 Adenoma Detection Rate (ADR) and Serrated Adenoma Detection Rate (Sdr) During Screening Colonoscopy With and Without a Personal Cancer History (Pch) in a Tertiary Referral Cancer Center Gastrointestinal Endoscopy. 79: AB202. DOI: 10.1016/J.Gie.2014.05.030  0.303
2013 Thosani N, Guha S, Singh H. Colonoscopy and colorectal cancer incidence and mortality. Gastroenterology Clinics of North America. 42: 619-37. PMID 23931863 DOI: 10.1016/J.Gtc.2013.05.011  0.332
2013 Aggarwal B, Prasad S, Sung B, Krishnan S, Guha S. Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature. Current Colorectal Cancer Reports. 9: 37-56. PMID 23814530 DOI: 10.1007/S11888-012-0154-1  0.354
2013 Thosani N, Guha S, Singh H. Oral bisphosphonates and colorectal cancer: cumulative dose and duration of use are important predictors of effect. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 1208. PMID 23591285 DOI: 10.1016/J.Cgh.2013.03.027  0.313
2013 Bhutani MS, Thosani N, Suzuki R, Guha S. Pancreatic cancer screening: what we do and do not know. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 731-3. PMID 23403010 DOI: 10.1016/J.Cgh.2013.02.004  0.351
2013 Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. Plos One. 8: e55171. PMID 23383312 DOI: 10.1371/Journal.Pone.0055171  0.321
2013 Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, et al. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas. Pancreas. 42: 494-501. PMID 23146921 DOI: 10.1097/Mpa.0B013E31826A8597  0.332
2013 Richards DM, Tanikella R, Arora G, Guha S, Dekovich AA. Percutaneous endoscopic gastrostomy in cancer patients: predictors of 30-day complications, 30-day mortality, and overall mortality. Digestive Diseases and Sciences. 58: 768-76. PMID 23007733 DOI: 10.1007/S10620-012-2397-8  0.303
2013 Batra S, Adeyefa B, Thosani N, Guha S. Increased Incidence of Colorectal Cancer in Patients with Prior Endometrial Cancer: A Populationbased U.S. Study: ACG Colorectal Cancer Prevention Award: 2130 The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-02130  0.356
2013 Ghouri Y, Thosani N, Batra S, Shafi M, Guha S. Lower Gastrointestinal Bleeding in Cancer Patients: Colonoscopic Findings: 622 The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-00622  0.359
2013 Rahimi E, Batra S, Thosani N, Guha S. Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Non-Pancreatic Malignancy: A Population-based US Study: Presidential Poster: 244 The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-00244  0.374
2012 Shukla A, Shukla S, Osowo A, Mashtare T, Bhutani MS, Guha S. Risk of colorectal adenomas in women with prior breast cancer. Digestive Diseases and Sciences. 57: 3240-5. PMID 23065089 DOI: 10.1007/S10620-012-2432-9  0.335
2012 Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A, Diagaradjane P, Wei C, Baladandayuthapani V, Krishnan S, Guha S, Aggarwal BB. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4942-53. PMID 22832932 DOI: 10.1158/1078-0432.Ccr-11-2805  0.354
2012 Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochimica Et Biophysica Acta. 1826: 129-69. PMID 22513004 DOI: 10.1016/J.Bbcan.2012.03.008  0.348
2012 Yuan J, Liu Y, Tan T, Guha S, Gukovsky I, Gukovskaya A, Pandol SJ. Protein kinase d regulates cell death pathways in experimental pancreatitis. Frontiers in Physiology. 3: 60. PMID 22470346 DOI: 10.3389/Fphys.2012.00060  0.383
2012 Matsuo Y, Takeyama H, Guha S. Cytokine network: new targeted therapy for pancreatic cancer. Current Pharmaceutical Design. 18: 2416-9. PMID 22372505 DOI: 10.2174/13816128112092416  0.373
2012 Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MS. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointestinal Endoscopy. 75: 242-53. PMID 22115605 DOI: 10.1016/J.Gie.2011.09.016  0.312
2012 Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets International Journal of Cancer. 131: E292-E303. PMID 21935918 DOI: 10.1002/Ijc.26442  0.408
2012 Yadav VR, Prasad S, Sung B, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. International Journal of Cancer. 130: 2176-84. PMID 21702037 DOI: 10.1002/Ijc.26251  0.345
2012 Thosani N, Ghouri Y, Batra S, Rao BB, Kumar S, Guha S. Relative Frequency of Upper Gastrointestinal Lesions and Outcomes in Cancer Patients with Suspected Upper Gastrointestinal Bleeding: 1519 The American Journal of Gastroenterology. 107. DOI: 10.14309/00000434-201210001-01519  0.302
2012 Thosani N, Thosani S, Kumar S, Nugent Z, Jimenez C, Singh H, Guha S. Su1021 Use of Oral Bisphosphonates and Risk of Colorectal Cancer: A Systemic Review and Meta-Analysis Gastroenterology. 142: S-402. DOI: 10.1016/S0016-5085(12)61523-6  0.304
2012 Thosani N, Kumar S, Shah S, Shafi MA, Davila ML, Dekovich AA, Guha S. Sa1722 Capsule Endoscopy Versus Position Emission Tomography for Detection of Metastatic Small Intestinal Melanoma: A Tertiary Cancer Center Experience Gastrointestinal Endoscopy. 75: AB254-AB255. DOI: 10.1016/J.Gie.2012.04.242  0.307
2011 Tong Z, Chakraborty S, Sung B, Koolwal P, Kaur S, Aggarwal BB, Mani SA, Bresalier RS, Batra SK, Guha S. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer. 117: 2408-18. PMID 24048788 DOI: 10.1002/Cncr.25803  0.336
2011 Wang W, Lin J, Guha S, Tong Z, Cameron AG, Zhang F, Qiu X, Zou C, Gao X, Mawad ME, Ke S. Target-specific agents imaging ectopic and orthotopic human pancreatic cancer xenografts. Pancreas. 40: 689-94. PMID 21654540 DOI: 10.1097/Mpa.0B013E31821F6B14  0.324
2011 Thrower EC, Yuan J, Usmani A, Liu Y, Jones C, Minervini SN, Alexandre M, Pandol SJ, Guha S. A novel protein kinase D inhibitor attenuates early events of experimental pancreatitis in isolated rat acini. American Journal of Physiology. Gastrointestinal and Liver Physiology. 300: G120-9. PMID 20947701 DOI: 10.1152/Ajpgi.00300.2010  0.363
2011 Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y, Yanagihara K, Yazumi S, Chiba T, Guha S, Aggarwal BB. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemotherapy and Pharmacology. 68: 157-64. PMID 20859741 DOI: 10.1007/S00280-010-1470-2  0.327
2011 Ochi N, Tanasanvimon S, Matsuo Y, Tong Z, Sung B, Aggarwal BB, Sinnett-Smith J, Rozengurt E, Guha S. Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells. Journal of Cellular Physiology. 226: 1074-81. PMID 20857418 DOI: 10.1002/Jcp.22421  0.517
2011 Richards D, Arora G, Tanikella R, Guha S, Dekovich A. Predictors of Major Complications within 30 Days of PEG Placement in Cancer Patients: 1410 The American Journal of Gastroenterology. 106. DOI: 10.14309/00000434-201110002-01410  0.32
2011 Tong Z, Chakraborty S, Sung B, Kaur S, Aggarwal BB, Mani S, Bresalier RS, Batra S, Guha S. Abstract 5008: Epidermal growth factor downregulates expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells Cancer Research. 71: 5008-5008. DOI: 10.1158/1538-7445.Am2011-5008  0.357
2011 Sinnett-Smith J, Guha S, Kisfalvi K, Rozengurt E. Protein Kinase D1 Mediates Mitogenic Signaling in Human Pancreatic Carcinoma PANC-1 Cells Gastroenterology. 140: S-713. DOI: 10.1016/S0016-5085(11)62961-2  0.509
2011 Baine M, Ochi N, Wallace MB, Woodward TA, Thomas CS, Guha S, Raimondo M. Ngal in Pancreatic Juice Helps to Discriminate Chronic Pancreatitis and Pancreatic Cancer Patients From Healthy Controls Gastroenterology. 140: S-35. DOI: 10.1016/S0016-5085(11)60139-X  0.364
2011 Yao Y, Tong Z, Reddy SA, Guha S. Biological Role of and Targeting Oncogenic Ki-RAS Induced a Novel AKT Regulator in Pancreatic Cancer Gastroenterology. 140: S-34. DOI: 10.1016/S0016-5085(11)60135-2  0.336
2010 Thosani N, Dasari CS, Bhutani MS, Raimondo M, Guha S. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 39: 1129-33. PMID 20881900 DOI: 10.1097/Mpa.0B013E3181F66Cdf  0.308
2010 Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. γ-Tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment Cancer Research. 70: 8695-8705. PMID 20864511 DOI: 10.1158/0008-5472.Can-10-2318  0.364
2010 Guha S, Tanasanvimon S, Sinnett-Smith J, Rozengurt E. Role of protein kinase D signaling in pancreatic cancer. Biochemical Pharmacology. 80: 1946-54. PMID 20621068 DOI: 10.1016/J.Bcp.2010.07.002  0.515
2010 Deorukhkar A, Shentu S, Park HC, Diagaradjane P, Puduvalli V, Aggarwal B, Guha S, Krishnan S. Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells. Pancreas. 39: 1277-83. PMID 20531243 DOI: 10.1097/Mpa.0B013E3181Dd63E1  0.36
2010 Harikumar KB, Sung B, Tharakan ST, Pandey MK, Joy B, Guha S, Krishnan S, Aggarwal BB. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products. Molecular Cancer Research : McR. 8: 751-61. PMID 20460401 DOI: 10.1158/1541-7786.Mcr-09-0565  0.357
2010 Harikumar KB, Kunnumakkara AB, Ochi N, Tong Z, Deorukhkar A, Sung B, Kelland L, Jamieson S, Sutherland R, Raynham T, Charles M, Bagherzadeh A, Bagherazadeh A, Foxton C, Boakes A, ... ... Guha S, et al. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Molecular Cancer Therapeutics. 9: 1136-46. PMID 20442301 DOI: 10.1158/1535-7163.Mct-09-1145  0.574
2010 Harikumar KB, Sung B, Pandey MK, Guha S, Krishnan S, Aggarwal BB. Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway. Molecular Pharmacology. 77: 818-27. PMID 20103608 DOI: 10.1124/Mol.109.062760  0.329
2010 Kisfalvi K, Hurd C, Guha S, Rozengurt E. Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells. Journal of Cellular Physiology. 223: 309-16. PMID 20082306 DOI: 10.1002/Jcp.22036  0.515
2010 Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S, Aggarwal BB. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. International Journal of Cancer. 127: 257-68. PMID 19908231 DOI: 10.1002/Ijc.25041  0.37
2010 Torres-Marquez E, Sinnett-Smith J, Guha S, Kui R, Waldron RT, Rey O, Rozengurt E. CID755673 enhances mitogenic signaling by phorbol esters, bombesin and EGF through a protein kinase D-independent pathway. Biochemical and Biophysical Research Communications. 391: 63-8. PMID 19896460 DOI: 10.1016/J.Bbrc.2009.11.002  0.502
2010 Matsuo Y, Sawai H, Ochi N, Yasuda A, Sakamoto M, Takahashi H, Funahashi H, Takeyama H, Guha S. Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking NF-kappaB activity. Digestive Diseases and Sciences. 55: 1167-76. PMID 19399612 DOI: 10.1007/S10620-009-0814-4  0.34
2010 Tong Z, Koolwal P, DeMars CJ, Buttar NS, Guha S. Abstract 3074: Neutrophil gelatinase-associated lipocalin inhibits proliferation of human esophageal adenocarcinoma cells bothin vitroandin vivo Cancer Research. 70: 3074-3074. DOI: 10.1158/1538-7445.Am10-3074  0.36
2010 Ochi N, Wallace MB, Woodward TA, Matsuo Y, Guha S, Raimondo M. T1401 Can Lipocalin 2/NGAL in Exocrine Pancreatic Secretions Distinguish Chronic Pancreatitis (CP) From Pancreatic Cancer (PC)? Gastroenterology. 138: S-554. DOI: 10.1016/S0016-5085(10)62553-X  0.35
2010 Kisfalvi K, Sinnett-Smith J, Guha S, Rozengurt E. M1969 Induced Overexpression of Protein Kinase D1 Stimulates Mitogenic Signaling in Human Pancreatic Carcinoma PANC-1 Cells Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)62079-3  0.506
2010 Torres-Marquez E, Sinnett-Smith J, Guha S, Rey O, Waldron RT, Rozengurt E. S1700 Cid755673 Enhances Mitogenic Signaling by Bombesin and EGF Through a Protein Kinase D-Independent Pathway Gastroenterology. 138: S-256. DOI: 10.1016/S0016-5085(10)61170-5  0.47
2010 Shukla S, Osowo A, Shukla A, Bhutani MS, Guha S. S1146 Colorectal Cancer Risk in Breast Cancer Survivors: A Retrospective Cohort Study Gastroenterology. 138: S-190. DOI: 10.1016/S0016-5085(10)60862-1  0.317
2010 Ireson CR, Harikumar KB, Kunnumakkara AB, Deorukhkar A, Tong Z, Maru D, Diagaradjane P, Ochi N, Krishnan S, Aggarwal BB, Rozengurt E, Guha S. 414 A Novel Small Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth Both In Vitro and In Vivo Gastroenterology. 138: S-62. DOI: 10.1016/S0016-5085(10)60282-X  0.529
2010 Deorukhkar A, Ahuja N, Mercado A, Diagaradjane P, Mohindra P, Guha S, Aggarwal B, Krishnan S. Zerumbone, a Sesquiterpene from Southeast Asian Edible Ginger Sensitizes Colorectal Cancer Cells to Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 78: S654. DOI: 10.1016/J.Ijrobp.2010.07.1522  0.318
2009 Bhutani MS, Verma D, Guha S, Lee JH, Richards-Kortum RR, Fleming JB. Is endoscopic ultrasound "sound" for pancreatic cancer screening? Journal of Clinical Gastroenterology. 43: 797-802. PMID 19652621 DOI: 10.1097/Mcg.0B013E3181B3Ab58  0.352
2009 Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Kuzhuvelil HB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. International Journal of Cancer. 125: 2187-97. PMID 19623659 DOI: 10.1002/Ijc.24593  0.351
2009 Matsuo Y, Campbell PM, Brekken RA, Sung B, Ouellette MM, Fleming JB, Aggarwal BB, Der CJ, Guha S. K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways. Molecular Cancer Research : McR. 7: 799-808. PMID 19509115 DOI: 10.1158/1541-7786.Mcr-08-0577  0.306
2009 Matsuo Y, Raimondo M, Woodward TA, Wallace MB, Gill KR, Tong Z, Burdick MD, Yang Z, Strieter RM, Hoffman RM, Guha S. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. International Journal of Cancer. Journal International Du Cancer. 125: 1027-37. PMID 19431209 DOI: 10.1002/Ijc.24383  0.363
2009 Chen G, Izzo J, Demizu Y, Wang F, Guha S, Wu X, Hung MC, Ajani JA, Huang P. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol. Antioxidants & Redox Signaling. 11: 1083-95. PMID 19187006 DOI: 10.1089/Ars.2008.2321  0.312
2009 Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Tong Z, Guha S. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. International Journal of Cancer. 124: 853-61. PMID 19035451 DOI: 10.1002/Ijc.24040  0.332
2009 Matsuo Y, Sawai H, Ochi N, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Guha S. Interleukin-1alpha secreted by pancreatic cancer cells promotes angiogenesis and its therapeutic implications. The Journal of Surgical Research. 153: 274-81. PMID 18952231 DOI: 10.1016/J.Jss.2008.04.040  0.324
2009 Shukla S, Shukla A, Bhutani M, Guha S. Colorectal Cancer Risk in Patients with Breast Cancer Survivors: Evidence from a Comprehensive Cancer Center: 1528 The American Journal of Gastroenterology. 104. DOI: 10.14309/00000434-200910003-01528  0.333
2009 Bektas M, Ross W, Lee J, Fleming J, Guha S, Bhutani M. EUS-FNA for Diagnosis of Cystic Pancreatic Neuroendocrine Tumors: An Important Cause for Pancreatic Cysts American Journal of Gastroenterology. 104: S541-S542. DOI: 10.14309/00000434-200910003-01441  0.308
2009 Ross W, Guha S, Lee J, Thatte R. Epidemiology and Endoscopic Management of Large Colon Polyps: Preliminary Analysis of a Cancer Center Experience: 490 The American Journal of Gastroenterology. 104. DOI: 10.14309/00000434-200910003-00490  0.329
2009 Ireson CR, Jamieson S, Stribbling S, Sutherland R, Raynham T, Williams J, Charles M, Bagherzadeh A, Farooq M, Harikumar KB, Kunnumakkara AB, Deorukhkar A, Tong Z, Maru D, Diagaradjane P, ... ... Guha S, et al. Abstract B261: A novel small molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vivo Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B261  0.397
2009 Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model (Molecular Cancer Therapeutics (2009) 8, (959-970)) Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Mct-08-5-Cor2  0.302
2009 Raimondo M, Matsuo Y, Woodward TA, Wallace MB, Gill KR, Ochi N, Tong Z, Strieter RM, Hoffman RM, Guha S. S2008 CXC-Chemokine/CXCR2 Biological Axis Promotes Angiogenesis In Vitro and In Vivo in Pancreatic Cancer Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)61424-4  0.373
2009 Thrower EC, Yuan J, Jones C, Usmani A, Kelly MK, Ireson C, Pandol SJ, Guha S. S1817 Protein Kinase D Modulates Secretagogue-Induced Zymogen Activation and Amylase Secretion in Rat Pancreatic Acinar Cells Gastroenterology. 136: A-276. DOI: 10.1016/S0016-5085(09)61259-2  0.326
2009 Kunnumakkara AB, Guha S, Aggarwal BB. Curcumin and colorectal cancer: Add spice to your life Current Colorectal Cancer Reports. 5: 5-14. DOI: 10.1007/S11888-009-0002-0  0.411
2008 Sung B, Jhurani S, Kwang SA, Mastuo Y, Yi T, Guha S, Liu M, Aggarwal BB. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells Cancer Research. 68: 8938-8944. PMID 18974138 DOI: 10.1158/0008-5472.Can-08-2155  0.36
2008 Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, Guha S. Neutrophil gelatinase-associated lipocalin: A novel suppressor of invasion and angiogenesis in pancreatic cancer Cancer Research. 68: 6100-6108. PMID 18676832 DOI: 10.1158/0008-5472.Can-08-0540  0.379
2008 Verma A, Guha S, Diagaradjane P, Kunnumakkara AB, Sanguino AM, Lopez-Berestein G, Sood AK, Aggarwal BB, Krishnan S, Gelovani JG, Mehta K. Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2476-83. PMID 18413840 DOI: 10.1158/1078-0432.Ccr-07-4529  0.338
2008 Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, et al. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Research. 68: 2632-40. PMID 18413730 DOI: 10.1158/0008-5472.Can-07-5460  0.322
2008 Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, Krishnan S. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2128-36. PMID 18381954 DOI: 10.1158/1078-0432.Ccr-07-4722  0.314
2008 Verma A, Guha S, Wang H, Fok JY, Koul D, Abbruzzese J, Mehta K. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1997-2005. PMID 18381937 DOI: 10.1158/1078-0432.Ccr-07-1533  0.358
2008 Raimondo M, Gill K, Wallace MB, Woodward TA, Matsuo Y, Guha S. CAN CXC-CHEMOKINES AND LIPOCALIN 2 IN PANCREATIC JUICE (PJ) DISTINGUISH CHRONIC PANCREATITIS (CP) FROM PANCREATIC CANCER (PC)? Pancreas. 37: 491. DOI: 10.1097/01.Mpa.0000335366.16890.3F  0.36
2008 Matsuo Y, Guha S. W1986 Cxcl8/IL-8 and Cxcl12/Sdf-1α Cooperatively Promote Invasion and Angiogenesis of Pancreatic Cancer Gastroenterology. 134: A-748. DOI: 10.1016/S0016-5085(08)63493-9  0.314
2008 Guha S, Verma A, Mehta K. 993 Tissue Transglutaminase Downregulation Potentiates Gemcitabine Efficacy and Blocks Pancreatic Cancer Growth In Vivo Gastroenterology. 134: A-149. DOI: 10.1016/S0016-5085(08)60693-9  0.359
2007 Pathak AK, Bhutani M, Nair AS, Ahn KS, Chakraborty A, Kadara H, Guha S, Sethi G, Aggarwal BB. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Molecular Cancer Research : McR. 5: 943-55. PMID 17855663 DOI: 10.1158/1541-7786.Mcr-06-0348  0.346
2007 Chakraborty A, Guha S. Granulocyte Colony-Stimulating Factor/Granulocyte Colony-Stimulating Factor Receptor Biological Axis Promotes Survival and Growth of Bladder Cancer Cells Urology. 69: 1210-1215. PMID 17572226 DOI: 10.1016/J.Urology.2007.02.035  0.304
2007 Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, Aggarwal BB. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3024-32. PMID 17505005 DOI: 10.1158/1078-0432.Ccr-06-2575  0.337
2007 Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Research. 67: 3853-61. PMID 17440100 DOI: 10.1158/0008-5472.Can-06-4257  0.388
2007 Matsuo Y, Ochi N, Takeyama H, Sawai H, Okada Y, Manabe T, Guha S. CXCL8/IL-8 AND CXCL12/SDF-1α COOPERATIVELY PROMOTE INVASION AND ANGIOGENESIS OF PANCREATIC CANCER Pancreas. 35: 415. DOI: 10.1097/01.Mpa.0000297743.73939.Dc  0.314
2007 Guha S, Verma S, Kunnumakkara A, Diagaradjane P, Krishnan S, Gelovani J, Aggarwal B, Lopez-Bernstein G, Mehta K. TISSUE TRANSGLUTAMINASE DOWNREGULATION POTENTIATES GEMCITABINE EFFICACY AND BLOCKS PANCREATIC CANCER GROWTH AND METASTASIS IN VIVO Pancreas. 35: 404-405. DOI: 10.1097/01.Mpa.0000297708.60477.45  0.365
2006 Chakraborty A, White SM, Guha S. Granulocyte colony-stimulating receptor promotes β1-integrin-mediated adhesion and invasion of bladder cancer cells Urology. 68: 208-213. PMID 16844458 DOI: 10.1016/J.Urology.2006.01.046  0.313
2005 Guha S, Eibl G, Kisfalvi K, Fan RS, Burdick M, Reber H, Hines OJ, Strieter R, Rozengurt E. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Research. 65: 2738-45. PMID 15805273 DOI: 10.1158/0008-5472.Can-04-3197  0.483
2005 Kisfalvi K, Guha S, Rozengurt E. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells. Journal of Cellular Physiology. 202: 880-90. PMID 15389644 DOI: 10.1002/Jcp.20187  0.462
2004 Kisfalvi K, Guha S, Rozengurt E. EFFECT OF NEUROTENSIN, BRADYKININ AND VASO-PRESSIN IN COMBINATION WITH EGF ON ERK SIGNALING, AND GROWTH OF HUMAN PANCREATIC CANCER. Pancreas. 29: 361. DOI: 10.1097/00006676-200411000-00134  0.535
2003 Guha S, Lunn JA, Santiskulvong C, Rozengurt E. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Cancer Research. 63: 2379-87. PMID 12750255  0.712
2003 Guha S, Santiskulvong C, Rozengurt E. Neurotensin stimulates PKC-dependent and EGFR-independent ERK activation in human pancreatic cancer Gastroenterology. 124: A467. DOI: 10.1016/S0016-5085(03)82363-6  0.737
2002 Rozengurt E, Guha S, Sinnett-Smith J. Gastrointestinal peptide signalling in health and disease. The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement. 23-38. PMID 16144198  0.424
2002 Guha S, Rey O, Rozengurt E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Research. 62: 1632-40. PMID 11912133  0.462
2001 Ryder NM, Guha S, Hines OJ, Reber HA, Rozengurt E. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation. Journal of Cellular Physiology. 186: 53-64. PMID 11147814 DOI: 10.1002/1097-4652(200101)186:1<53::Aid-Jcp1004>3.0.Co;2-Q  0.456
2001 Guha S, Rozengurt E. Protein kinase C (PKC) plays a pivotal role in neurotensin (NT) mediated signaling in human ductal pancreatic cancer cells Gastroenterology. 120: A309. DOI: 10.1016/S0016-5085(08)81535-1  0.54
Show low-probability matches.